Skip to content
10-K

Annual Report

VYANT BIO, INC

0001493152-23-010255

← back to feed
Filed
Mar 31, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Mar 15, 2023 6.27M sh
Shares Diluted FY 2022 · Dec 31, 2022 5.87M sh
Shares Diluted FY 2022 · Dec 31, 2021 4.52M sh
Capex FY 2022 · Dec 31, 2022 $617K
Capex FY 2022 · Dec 31, 2021 $535K
Operating Cash Flow FY 2022 · Dec 31, 2022 −$13.68M
Operating Cash Flow FY 2022 · Dec 31, 2021 −$16.99M
Long Term Debt FY 2022 · Dec 31, 2022 $57K
Long Term Debt FY 2022 · Dec 31, 2021 $57K
Cash And Equivalents FY 2022 · Dec 31, 2022 $10.04M
Cash And Equivalents FY 2022 · Dec 31, 2021 $20.61M
Stockholders Equity FY 2022 · Dec 31, 2022 $9.91M
Stockholders Equity FY 2022 · Dec 31, 2021 $31.29M
Stockholders Equity restated FY 2022 · Dec 31, 2020 −$36.44M
Current Liabilities FY 2022 · Dec 31, 2022 $3.67M
Current Liabilities FY 2022 · Dec 31, 2021 $5.43M
Total Liabilities FY 2022 · Dec 31, 2022 $5.3M
Total Liabilities FY 2022 · Dec 31, 2021 $6.35M
Current Assets FY 2022 · Dec 31, 2022 $11.51M
Current Assets FY 2022 · Dec 31, 2021 $23.21M
Total Assets FY 2022 · Dec 31, 2022 $15.21M
Total Assets FY 2022 · Dec 31, 2021 $37.64M
Eps Basic FY 2022 · Dec 31, 2022 −$3.87
Eps Basic FY 2022 · Dec 31, 2021 −$9.03
Rd Expense FY 2022 · Dec 31, 2022 $6.77M
Rd Expense FY 2022 · Dec 31, 2021 $4.27M
Net Income FY 2022 · Dec 31, 2022 −$22.69M
Net Income FY 2022 · Dec 31, 2021 −$40.86M
Operating Income FY 2022 · Dec 31, 2022 −$15.91M
Operating Income FY 2022 · Dec 31, 2021 −$15.71M
Revenue FY 2022 · Dec 31, 2022 $666K
Revenue FY 2022 · Dec 31, 2021 $1.15M